INS and insulin-resistant diabetes mellitus: Metformin (1,1‐dimethylbiguanide) is the first line of therapy in insulin‐resistant diabetes due to its ability to prevent hepatic gluconeogenesis, increase peripheral glucose uptake, and improve insulin sensitivity (Rena et al., 2017).